Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Atossa Genetics Inc

+ Add to Watchlist

ATOS:US

1.6300 USD 0.0300 1.81%

As of 20:10:00 ET on 04/17/2015.

Snapshot for Atossa Genetics Inc (ATOS)

Open: 1.6600 Day's Range: 1.6000 - 1.6600 Volume: 136,203
Previous Close: 1.6600 52wk Range: 0.8000 - 2.6500 1-Yr Rtn: +25.38%

Stock Chart for ATOS

No chart data available.
  • ATOS:US 1.6300
  • 1D
  • 1M
  • 1Y
1.6600
Interactive ATOS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATOS

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5200
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 37.94
Shares Outstanding (M) 23.28
30 Day Average Volume 388,083
Price/Book (mrq) 4.2155
Price/Sale (ttm) 70.9034
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATOS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATOS

Atossa Genetics Inc. is a development-stage healthcare company. The Company is focused on the commercialization of cellular and molecular diagnostic risk assessment products and related services for the detection of pre-cancerous conditions that could lead to breast cancer, and on the development of second-generation products and services.

Steven C QuayChairman/President/CEOKyle GuseCFO/Secretary/General Counsel
Pieter Van Der PoelVP:European Commercial OpsVP:Sales & Marketing
More Company Profile & Key Executives for ATOS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil